DROTBLAZE M

Introduction

DROTBLAZE M is a prescription medicine containing Drotaverine Hydrochloride 80 mg and Mefenamic Acid 250 mg, a well-established combination used for the symptomatic relief of spasmodic pain caused by smooth muscle spasm.

Drotaverine is an antispasmodic agent that relieves smooth muscle spasm without affecting normal intestinal motility, while Mefenamic Acid is a non-steroidal anti-inflammatory drug (NSAID) that provides analgesic and anti-inflammatory effects by reducing prostaglandin synthesis. Together, these complementary mechanisms help relieve abdominal cramps, menstrual pain, and colicky pain associated with smooth muscle spasm.

When prescribed by a healthcare professional, DROTBLAZE M provides effective relief from pain and muscle spasm, improving patient comfort and daily functioning.

Uses of DROTBLAZE M

DROTBLAZE M is indicated for the symptomatic relief of spasmodic pain.

It may be prescribed for:

1. Primary dysmenorrhea (menstrual cramps)
2. Gastrointestinal colic
3. Biliary colic
4. Renal colic
5. Pain associated with smooth muscle spasm of the gastrointestinal and genitourinary tract

Note: DROTBLAZE M provides symptomatic relief and should be used only under the guidance of a qualified healthcare professional.

Benefits of DROTBLAZE M

DROTBLAZE M combines an antispasmodic agent with an NSAID to provide comprehensive relief from spasmodic pain.

Scientific benefits include:

1. Provides effective relief from pain and smooth muscle spasm.
2. Helps reduce abdominal cramps associated with gastrointestinal and genitourinary disorders.
3. Relieves menstrual pain by reducing uterine smooth muscle spasm and prostaglandin-mediated pain.
4. Helps relieve colicky pain associated with biliary and renal conditions.
5. Improves patient comfort and daily activities by reducing pain intensity.
6. Fixed-dose combination offers convenient administration and may improve treatment adherence.

How DROTBLAZE M Works

DROTBLAZE M works through the complementary pharmacological actions of its two active ingredients.

Drotaverine Hydrochloride is a selective antispasmodic that inhibits phosphodiesterase-IV (PDE-IV), leading to relaxation of smooth muscles in the gastrointestinal, biliary, urinary, and uterine systems. This helps relieve painful muscle spasms without significant anticholinergic effects.

Mefenamic Acid is a non-steroidal anti-inflammatory drug (NSAID) that inhibits cyclooxygenase (COX-1 and COX-2) enzymes, reducing the production of prostaglandins responsible for pain and inflammation. In primary dysmenorrhea, reduced prostaglandin synthesis helps decrease uterine contractions and menstrual pain.

Together, these complementary mechanisms provide effective relief from spasmodic pain, abdominal cramps, and inflammation.

Dosage & Administration

DROTBLAZE M should be used only under the supervision of a qualified healthcare professional.

General Adult Dosage

1. Take the tablet exactly as prescribed by your physician.
2. The tablet is preferably taken after food with a glass of water to minimize gastric irritation.
3. Swallow the tablet whole without crushing or chewing.
4. The dosage and duration of treatment should be individualized according to the patient's clinical condition and therapeutic response.
5. Do not exceed the prescribed dose or duration of therapy.

Possible Side Effects

Like all medicines, DROTBLAZE M may cause side effects, although not everyone experiences them.

Commonly reported side effects include:

1. Nausea
2. Vomiting
3. Indigestion
4. Abdominal discomfort
5. Diarrhea
6. Dizziness
7. Headache

Patients should seek immediate medical attention if they develop signs of gastrointestinal bleeding (such as black stools or vomiting blood), severe allergic reactions, severe skin reactions, or persistent abdominal pain.

Contraindications & Precautions

DROTBLAZE M should not be used in patients with:

1. Known hypersensitivity to Drotaverine, Mefenamic Acid, NSAIDs, or any component of the formulation.
2. Active peptic ulcer disease or gastrointestinal bleeding.
3. Severe hepatic impairment.
4. Severe renal impairment.
5. Severe heart failure.
6. History of aspirin- or NSAID-induced asthma or hypersensitivity reactions.

Important Precautions

DROTBLAZE M should be used with caution in patients with:

1. Mild to moderate hepatic or renal impairment.
2. Elderly patients.
3. History of gastrointestinal disorders.
4. Hypertension or cardiovascular disease.
5. Bleeding disorders or patients receiving anticoagulant therapy.
6. Pregnancy or breastfeeding, only if considered appropriate by the treating physician.

Patients should inform their healthcare provider about all prescription medicines, over-the-counter medicines, herbal products, and dietary supplements before starting DROTBLAZE M, as clinically significant drug interactions may occur.

Disclaimer

The information provided on this page is intended for educational purposes only and should not replace professional medical advice, diagnosis, or treatment. DROTBLAZE M is a prescription medicine and should be used only under the supervision of a qualified healthcare professional. Patients should always follow their physician's advice regarding dosage, duration of treatment, and monitoring. Clinical decisions should be individualized based on the patient's medical condition, medical history, and current evidence-based clinical guidelines.